Study objective-The aims were (1) In this paper, a multiplicative age-cohort model is fitted to cancer incidence rates of Saarland, Germany, in order to describe concisely the relative incidence of various birth cohorts and to estimate future cancer incidence rates.
Setting-The study was population based involving the whole state of Saarland.
Patients-80 028 cases of malignant neoplasms (other than non-melanoma skin cancer) diagnosed from 1968 to 1987 and reported to the cancer registry of Saarland were included.
Measurements and main results-Age specific, sex specific, and period specific cancer incidence rates were analysed and extrapolated by multiplicative age-cohort models. Due to a steady rise in birth cohort specific cancer incidence rates in males, a substantial rise in incidence of total cancer is projected, while a moderate decline is expected for females. Analogous analyses are presented for the most common single forms of cancer in women and men. Alternative strategies of analysis, such as age-period-cohort modelling, are discussed.
Conclusions-The age-cohort model is well suited for monitoring incidence ofmost forms of cancer. The projections provide quantitative guidelines for planning of health care resources and underline and quantify the challenge for primary and secondary cancer prevention in Saarland.
Surveillance of chronic disease occurrence in populations is most commonly based on monitoring of time trends in age specific and age standardised mortality or (if population based disease registers are available) incidence rates. This also applies to malignant neoplasms although it is usually biologically more plausible that changes in population based cancer rates follow birth cohort rather than calendar period patterns.' 2 Basic descriptive techniques of birth cohort analysis34 have been supplemented by various forms of mathematical modelling in the past two decades. Most estimates "standardised incidence ratios" for successive birth cohorts. For simplification, the terms "cohort standardised incidence ratios" and "cohort effects" are used interchangeably from now on. The statistical modelling was carried out using the software package GLIM.13 In order to stabilise the parameter estimates for the youngest birth cohorts, which is crucial for the purpose of prediction, a common cohort parameter was estimated for the cohorts with central years ofbirth Analogous procedures were applied in the analysis and projection of incidence rates of the most common single forms of cancer starting from suited lower age limits: 30 years for breast and cervical cancer; 40 years for cancer of the stomach, colon, rectum, lung, corpus uteri and ovaries, and 45 years for prostate cancer. Again, in each model, a common cohort effect was estimated for the two youngest birth cohorts under consideration, which was then also applied to subsequent birth cohorts (table II) . In addition, cancer incidence rates below the lower age limit were assumed to remain constant from 1983-1987 to 1988-2002 in the projections of future incidence rates (these rates have only minimal impact on overall age standardised incidence rates).
Results
A rough a priori check of the appropriateness of the multiplicative age-cohort model, which is always advisable, is shown for all forms of cancer (ICD-9 positions 140-208 excluding position 173) in fig 1 . If the multiplicative assumption holds, the age specific incidence rates, displayed by birth cohorts in a semilogarithmic plot, should follow parallel lines, which is approximately true. While standardised incidence ratios were slightly falling for the younger female cohorts beginning with the 1923 birth cohort, a steady and steep increase in relative incidence was observed for male cohorts. The model fit was within an acceptable range for women (deviance = 40 1 at 35 degrees of freedom), but less satisfactory for men (deviance= 77 5 at 35 degrees of freedom). .tb 4 0 't P pol N *,Cb activity, which is likely to follow period rather than cohort patterns. In fact, there was a sharp rise of detection rates of prostate cancer in the 1970s as a result of intensified diagnostic activity. Results for prostate cancer should therefore be interpreted with caution and are mainly shown for illustrative purposes. Alternative procedures to project prostate cancer "incidence" would be a political rather than a scientific issue, depending on the desired level of prostate cancer detection rates. Interestingly, the model fit was excellent for cervical cancer, although a transient rise in detection rates ofpreinvasive lesions followed by a sharp decline in incidence rates of invasive cervical cancer in the 1970s might suggest a pronounced period effect of the nationwide screening programme initiated in 1971, which was offered to all age groups above 30 years. ' Calendar period
Calendar period
Recent changes in risk factor profiles may modify the projected future cancer incidence rates. As most of the effects of such changes cannot be quantified with satisfactory accuracy due to lack of sufficiently detailed data on risk factor prevalence, we decided to address them in a solely qualitative manner here. For example, the sex differences in lung cancer incidence may diminish more rapidly due to changes in smoking behaviour. Similarly, the increase in breast cancer incidence may be further accelerated by the trend toward delayed childbearing in younger birth cohorts.'7 Given the continuing rise of breast cancer mortality in Germany'8 this stresses the need for implementation of a more effective breast cancer screening programme.
The increase in incidence rates of young male cohorts and the observed and projected rise of overall incidence in men are particularly alarming. While for women a substantial reduction in cervical cancer, most likely a result of population-wide screening,16 could be observed, no comparable success has so far been achieved for any form of cancer in men. Furthermore 
